Literature DB >> 12407136

Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections.

Steffen Borrmann1, Nicole Szlezák, Ronald K Binder, Michel A Missinou, Bertrand Lell, Peter G Kremsner.   

Abstract

This study evaluated the efficacy and safety of a 3-day course of artesunate (4 mg/kg/day) for asymptomatic Plasmodium malariae infections. The parasitological cure rates on days 7 and 56 in the group treated with artesunate were 100% and 83%, respectively, compared with no cure in the placebo group (P < 0.0001).

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12407136     DOI： 10.1093/jac/dkf200

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  8 in total

1.  Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.

Authors:  Steffen Borrmann; Ingrid Lundgren; Sunny Oyakhirome; Bénido Impouma; Pierre-Blaise Matsiegui; Ayola A Adegnika; Saadou Issifou; Jürgen F J Kun; David Hutchinson; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.

Authors:  Steffen Borrmann; Ayola A Adegnika; Félicien Moussavou; Sunny Oyakhirome; Gilbert Esser; Pierre-Blaise Matsiegui; Michael Ramharter; Ingrid Lundgren; Maryvonne Kombila; Saadou Issifou; David Hutchinson; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 3.  Artemisinins.

Authors:  C J Woodrow; R K Haynes; S Krishna
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

Review 4.  Artemisinin combination therapy for vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Brian J Angus; Francois Nosten; Ric N Price
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

5.  Effects of Plasmodium falciparum parasite population size and patient age on early and late parasitological outcomes of antimalarial treatment in children.

Authors:  Steffen Borrmann; Pierre-Blaise Matsiegui; Michel Anoumou Missinou; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

6.  Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon.

Authors:  Ghyslain Mombo-Ngoma; Christian Kleine; Arti Basra; Heike Würbel; Daisy A Diop; Mesküre Capan; Ayola A Adegnika; Florian Kurth; Benjamin Mordmüller; Fanny Joanny; Peter G Kremsner; Michael Ramharter; Sabine Bélard
Journal:  Malar J       Date:  2012-07-10       Impact factor: 2.979

Review 7.  Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.

Authors:  Benjamin J Visser; Rosanne W Wieten; Daniëlle Kroon; Ingeborg M Nagel; Sabine Bélard; Michèle van Vugt; Martin P Grobusch
Journal:  Malar J       Date:  2014-11-26       Impact factor: 2.979

8.  Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar.

Authors:  Yupawadee Pimpat; Naowarat Saralamba; Usa Boonyuen; Sasithon Pukrittayakamee; Francois Nosten; Frank Smithuis; Nicholas P J Day; Arjen M Dondorp; Mallika Imwong
Journal:  Malar J       Date:  2020-08-31       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.